Back to results
US 6,486,198 B1Granted
Compounds and methods for the treatment of post traumatic stress disorder
OwnerJeffrey Berlantinventor
Life of this patent
Estimating the term…
Abstract
The application relates to the use of topiramate and related sulfamates for the treatment and/or prophylaxis of post traumatic stress disorder (PTSD).
Claims8
A method for treating post traumatic stress disorder comprising administering to a mammal afflicted therewith a therapeutically effective amount of a compound of the formula I:
- wherein
- X is CH2 or oxygen;
- R1 is hydrogen or alkyl;
- and
- R2, R3, R4 and R5 are independently hydrogen or lower alkyl and, when X is CH2, R4 and R5 may be alkene groups joined to form a benezene ring and, when X is oxygen, R2 and R3 and/or R4 and R5 together may be a methylenedioxy group of the following formula (II):
- wherein R6 and R7 are the same or different and are hydrogen, lower alkyl or are alkyl and are joined to form a cyclopentyl or cyclohexyl ring;
- or a pharmacologically acceptable acid addition salt thereof, alone or in association with a pharmaceutically acceptable carrier.
4 more elements
A method for treating a mammalian patient comprising determining that the patient suffers from post traumatic stress disorder, and then administering to the patient a therapeutically effective amount of a compound of the formula I:
- wherein
- X is CH2 or oxygen;
- R1 is hydrogen or alkyl;
- and
- R2, R3, R4 and R5 are independently hydrogen or lower alkyl and, when X is CH2, R4 and R5 may be alkene groups joined to form a benezene ring and, when X is oxygen, R2 and R3 and/or R4 and R5 together may be a methylenedioxy group of the following formula (II):
- wherein R6 and R7 are the same or different and are hydrogen, lower alkyl or are alkyl and are joined to form a cyclopentyl or cyclohexyl ring;
- or a pharmacologically acceptable acid addition salt thereof, alone or in association with a pharmaceutically acceptable carrier.
4 more elements
Dependencies are inferred from the claim text.